approval
saveVITAMIN K1 (PHYTONADIONE) — FDA approval
community read0 votes
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- phase 2 completionTufts Medical Center — phytonadione (Phase II Trial Completion)Apr 30, 2026 · 153d ago
- approvalVITAMIN K1 (PHYTONADIONE) — FDA approvalMar 6, 2026 · 208d ago
- approvalVITAMIN K1 (PHYTONADIONE) — FDA approvalMar 6, 2026 · 208d ago
- approvalPHYTONADIONE — FDA approvalFeb 26, 2026 · 216d ago
- approvalPHYTONADIONE — FDA approvalFeb 26, 2026 · 216d ago
- approvalPHYTONADIONE — FDA approvalNov 4, 2025 · 330d ago
- approvalVITAMIN K1 (PHYTONADIONE) — FDA approvalOct 7, 2004 · 8028d ago
- approvalVITAMIN K1 (PHYTONADIONE) — FDA approvalOct 6, 2004 · 8029d ago
same company · ±60 days · 6
- approvalPHYTONADIONE: VITAMIN K1 (PHYTONADIONE) — FDA approvalJul 19, 1999
- approvalNALBUPHINE HYDROCHLORIDE: NALBUPHINE HYDROCHLORIDE — FDA approvalJul 12, 1999
- approvalNALBUPHINE HYDROCHLORIDE: NALBUPHINE HYDROCHLORIDE — FDA approvalJul 12, 1999
- approvalNALBUPHINE HYDROCHLORIDE: NALBUPHINE HYDROCHLORIDE — FDA approvalJul 12, 1999
- approvalNALBUPHINE HYDROCHLORIDE: NALBUPHINE HYDROCHLORIDE — FDA approvalJul 12, 1999
- approvalEffentora: FENTANYL CITRATE — FDA approvalAug 4, 1999
🐶 often sniffed alongside
top 8- tagApproval142 co-mentions · 38 sources
- drugVITAMIN K1139 co-mentions · 40 sources
- companyCipla USA Inc1 co-mentions · 1 sources
- companyCipla Ltd1 co-mentions · 1 sources
- companyTufts Medical Center1 co-mentions · 1 sources
- tagOrthopedics1 co-mentions · 1 sources
- tagSmall Molecule1 co-mentions · 1 sources
- tagRecall1 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that